BTH1704
BTH1704 is a human monoclonal antibody (mAb) targeting MUC1. BTH1704 enables PGG-primed leukocytes to kill iC3b-opsonized tumor cells. BTH1704 can be used in pancreatic and breast cancer research[1].
Product Specifications
UNSPSC
12352203
Target
Mucin
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[BTH1704]
References & Citations
[1]Venepalli N K, et al. Phase Ib study of PGG beta glucan in combination with anti-MUC1 antibody (BTH1704) and gemcitabine for the treatment of advanced pancreatic cancer[J]. 2015.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NSL1790Hu 96 Tests
Human Cross Linked N-Telopeptide Of Type I Collagen (NTXI) ELISA Kit
Ask
View Details